Medicare Enrolled

Dr. Swarna Sivanesan, M.D.

Dermatology · Freehold, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
901 W MAIN ST, Freehold, NJ 07728
7326379982
In practice since 2007 (19 years)
NPI: 1104024165 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sivanesan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sivanesan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sivanesan

Dr. Swarna Sivanesan is a dermatology specialist in Freehold, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sivanesan performed 4,480 Medicare services across 2,038 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sivanesan received a total of $134,948 from 38 pharmaceutical and/or device companies across 653 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sivanesan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 21% volume in NJ $134,948 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,480
Medicare services
Top 21% in NJ for dermatology
2,038
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~236 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
1,672 $6 $16
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
774 $74 $196
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
466 $41 $149
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
450 $106 $276
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
407 $99 $255
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
329 $76 $228
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
112 $45 $113
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
97 $85 $243
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
67 $131 $359
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
30 $148 $377
Intermediate wound repair, 2.5 cm or less
This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing.
24 $235 $590
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
22 $158 $398
Removal of noncancer skin growth, 0.6-1.0 cm
This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter.
16 $70 $349
Destruction of cancer skin growth, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters.
14 $128 $330
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$134,948
Total received (2018-2024)
Avg $19,278/year across 7 years
Top 4% in NJ for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
653
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$126,500 (93.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,599 (4.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,850 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$26,121
2023
$31,563
2022
$20,130
2021
$13,398
2020
$8,611
2019
$16,701
2018
$18,424

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$24,069
Incyte Corporation
$456
MAYNE PHARMA COMMERCIAL LLC
$397
SUN PHARMACEUTICAL INDUSTRIES INC.
$377
Medimetriks Pharmaceuticals, Inc.
$350
GENZYME CORPORATION
$150
LEO Pharma Inc.
$109
Dermavant Sciences, Inc.
$65
Regeneron Healthcare Solutions, Inc.
$44
PFIZER INC.
$31
Kyowa Kirin, Inc.
$31
E.R. Squibb & Sons, L.L.C.
$28
Janssen Biotech, Inc.
$14
Top 3 companies account for 95.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$92,292
Celgene Corporation
$28,234
Promius Pharma LLC
$4,301
Medimetriks Pharmaceuticals, Inc.
$1,850
Biofrontera Inc.
$933
Encore Dermatology Inc.
$902
MAYNE PHARMA COMMERCIAL LLC
$735
Incyte Corporation
$682
Sun Pharmaceutical Industries Inc.
$537
SUN PHARMACEUTICAL INDUSTRIES INC.
$459
Janssen Biotech, Inc.
$440
Dermavant Sciences, Inc.
$386
GENZYME CORPORATION
$359
VYNE Pharmaceuticals Inc.
$320
MAYNE PHARMA INC.
$302
Ortho Dermatologics, a division of Bausch Health US, LLC
$301
Arcutis Biotherapeutics, Inc.
$217
Regeneron Healthcare Solutions, Inc.
$205
Lilly USA, LLC
$173
EPI Health, LLC
$158
LEO Pharma Inc.
$147
Janssen Scientific Affairs, LLC
$146
PFIZER INC.
$136
ABBVIE INC.
$120
Mayne Pharma Inc.
$110
Journey Medical Corporation
$76
Genentech USA, Inc.
$74
Taro Pharmaceuticals USA, Inc.
$64
E.R. Squibb & Sons, L.L.C.
$61
Almirall LLC
$58
Glenmark Therapeutics Inc.
$42
Kyowa Kirin, Inc.
$31
Exeltis, USA Inc.
$22
Organogenesis Inc.
$17
Novartis Pharmaceuticals Corporation
$15
AbbVie Inc.
$15
TARO PHARMACEUTICALS USA, INC.
$14
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 92.5% of all-time payments
Associated products mentioned in payments ›
0.25% · ADBRY · AMELUZ · AMZEEQ · ARAZLO · Acticlate · Ameluz · BRYHALI · Bensal HP · CIBINQO · CLODERM · COSENTYX · Cloderm Cream · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EUCRISA · Ecoza · Erivedge · Exelderm · Halog · ILUMYA · Ilumya · Impoyz · JUBLIA · JUBLIA EFINACONAZOLE · LUZU LULICONAZOLE · Mupirocin Cream · Neo-Synalar · OLUMIANT · OPZELURA · Otezla · Poteligeo · Puraply · QBREXZA · REMICADE · RINVOQ · SILIQ · SIVEXTRO · Sernivo · Sernivo Spray · Seysara · Sitavig · Sotyktu · Sumadan Wash · TALTZ · TETRIX · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TRIANEX 0.05% · Tremfya · Trianex · ULTRAVATE (halobetasol propionate) lotion · VTAMA · Veltin · Verdeso · WYNZORA · Winlevi · ZILXI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for dermatology in NJ.

Looking for a dermatology specialist in Freehold?
Compare dermatologists in the Freehold area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
96
Per 100K population
14.9
County median income
$122,727
Nearest hospital
CENTRASTATE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sivanesan is a clinical cardiology specialist, with above-average Medicare volume (top 21% in NJ), with speaking/promotional industry engagement in the top 4% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sivanesan experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Sivanesan performed 1,672 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sivanesan receive payments from pharmaceutical companies?
Yes. Dr. Sivanesan received a total of $134,948 from 38 companies across 653 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sivanesan's costs compare to other dermatologists in Freehold?
Dr. Sivanesan's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sivanesan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →